Xenon Pharmaceuticals Inc. (FRA:XP0)
Germany · Delayed Price · Currency is EUR 34.80
+0.20 (0.58%)
At close: Jan 30, 2026
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of €2.67 billion as of January 30, 2026. Its market cap has decreased by -10.30% in one year.
Market Cap
2.67B
Enterprise Value
2.21B
Revenue
6.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
€34.80
Market Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from 114.25M to 2.67B, an increase of 2,234.74%. That is a compound annual growth rate of 32.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.67B | -9.57% |
| Dec 31, 2025 | 2.95B | 2.19% |
| Dec 31, 2024 | 2.89B | -8.90% |
| Dec 29, 2023 | 3.17B | 37.33% |
| Dec 30, 2022 | 2.31B | 59.69% |
| Dec 31, 2021 | 1.45B | 219.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |